Medical devices company Aran Biomedical revealed on Monday the appointment of Todd Blair as vice president of its Sales and Business Development (US) to meet and manage the growing demand for its implantable biomaterial product solutions.
Effective 1 July 2020, Blair will support, identify and develop the company's new business opportunities into sustainable and long-term partnerships, lead internal teams on proposal and product solution development as well as oversee the sales and business development activities in the US marketplace with a primary focus on the Orthopaedic, General Surgery and Vascular fields.
Most recently, Blair has served as vice president of Corporate Strategy at Heraeus Medical Components.
The company said Todd brings to the new position more than 20 years of experience in sales and business development within the life sciences contract manufacturing industry, with a focus on Bio-Textiles, Nitinol devices and polymeric components.
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe
Ocular Therapeutix prices USD475m common stock offering
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
AstraZeneca launches online platform to expand patient access to medications
Avant Technologies enters joint venture to advance stem cell-based diabetes treatments
Innovent and Ollin report progress in development of OLN324 (IBI324)
Alteogen secures European Commission approval for aflibercept biosimilar EYLUXVI
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Ascletis presents ASC30 study results at EASD Annual Meeting
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes